本頁面由Tiger Trade Technology Pte. Ltd.提供服務

VYNE Therapeutics Inc.

0.3738
+0.00381.03%
成交量:38.10萬
成交額:14.31萬
市值:1,244.25萬
市盈率:-0.47
高:0.3800
開:0.3781
低:0.3702
收:0.3700
52周最高:4.30
52周最低:0.2805
股本:3,328.64萬
流通股本:3,082.31萬
量比:0.77
換手率:1.24%
股息:- -
股息率:- -
每股收益(TTM):-0.7884
每股收益(LYR):-0.9353
淨資產收益率:-70.67%
總資產收益率:-41.51%
市淨率:0.39
市盈率(LYR):-0.40

資料載入中...

2024/05/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/03/13

SEC問詢函

Form CORRESP - Correspondence
2024/03/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/01

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/13

重要事件披露

Form 8-K - Current report
2023/12/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/20

SEC問詢函

Form CORRESP - Correspondence
2023/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/13

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/11/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/03

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/30

重要事件披露

Form 8-K - Current report